Development of a porcine model of polycystic kidney disease by multiplex gene-editing.
Award amount
$352,419Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Recombinetics, Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- L99NWZNZ7K57
- Solicitation number
- PA13-092
- Topic code
- NIDDK
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Gene Therapy for MPS IV A in a Novel Porcine Model of the Disease
- An Inducible Swine Hepatocellular Carcinoma Platform for Enhanced Therapeutic Development
- Development and Evaluation of a Thrombospondin 2 Deficient Pig as an Improved Source of Biomaterial
- Swine model of monogenic diabetes with potential implications for T1D, T2D, and double diabetes
- Development and Characterization of a Preclinical Swine Model of Osteogenesis Imperfecta
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1b
- Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes
- Novel Over-the-Scope Platform for Control of Variceal Bleeding
- Tolerogenic Nanotherapy to Delay Type I Diabetes
- An intravascular Bioartificial Pancreas (iBAP)
Research funding history
20 SBIR/STTR records share this UEI (2011–2024). Reported award amounts total $9,634,813. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services